A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : mSOD1 / mutant superoxide dismutase 1

[Related PubMed/MEDLINE]
Total Number of Papers: 20
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   mSOD1  (>> Co-occurring Abbreviation)
Long Form:   mutant superoxide dismutase 1
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions. ALS, GUDCA, LPS, MNs, VS, WT
2018 Single-cell mass cytometry reveals distinct populations of brain myeloid cells in mouse neuroinflammation and neurodegeneration models. ALS, EAE, HD
2018 Temporospatial Analysis and New Players in the Immunology of Amyotrophic Lateral Sclerosis. ALS, CNS and PNS, MN, NMJ
2014 Extensive dysregulations of oligodendrocytic and astrocytic connexins are associated with disease progression in an amyotrophic lateral sclerosis mouse model. ALS, AQP4, Cxs, EAAT2, GFAP, GJs, MOG, mSOD1-Tg, non-Tg
2013 Impaired cytoplasmic-nuclear transport of hypoxia-inducible factor-1alpha in amyotrophic lateral sclerosis. AHCs, ALS, HIF-1alpha, Nup62, VEGF
2013 Transglutaminase 2 accelerates neuroinflammation in amyotrophic lateral sclerosis through interaction with misfolded superoxide dismutase 1. ALS, SOD1, TG2
2012 Impaired recruitment of neuroprotective microglia and T cells during acute neuronal injury coincides with increased neuronal vulnerability in an amyotrophic lateral sclerosis model. ALS, NTG
2012 Protein misfolding, mitochondrial dysfunction and muscle loss are not directly dependent on soluble and aggregation state of mSOD1 protein in skeletal muscle of ALS. CK, fALS, GAPDH, ROS
2011 Abnormal changes in NKT cells, the IGF-1 axis, and liver pathology in an animal model of ALS. alpha-GalCer, ALS, IGF, IGFBP, MN, NKT
10  2011 Astrocytes carrying the superoxide dismutase 1 (SOD1G93A) mutation induce wild-type motor neuron degeneration in vivo. MN
11  2011 Excess circulating alternatively activated myeloid (M2) cells accelerate ALS progression while inhibiting experimental autoimmune encephalomyelitis. ALS, CNS, EAE, MDSCs, SALS
12  2010 Effects of facial nerve axotomy on Th2-associated and Th1-associated chemokine mRNA expression in the facial motor nucleus of wild-type and presymptomatic SOD1 mice. ALS, CNS, FMN, WT
13  2010 Evidence from computer simulations for alterations in the membrane biophysical properties and dendritic processing of synaptic inputs in mutant superoxide dismutase-1 motoneurons. ALS, WT
14  2010 Neuroprotection by gene therapy targeting mutant SOD1 in individual pools of motor neurons does not translate into therapeutic benefit in fALS mice. AAV6, ALS, MN, shRNAs
15  2009 Mitochondrial ubiquitin ligase MITOL ubiquitinates mutant SOD1 and attenuates mutant SOD1-induced reactive oxygen species generation. ROS
16  2007 Adult olfactory bulb neural precursor cell grafts provide temporary protection from motor neuron degeneration, improve motor function, and extend survival in amyotrophic lateral sclerosis mice. MNs, NPC, OB
17  2007 Sodium valproate exerts neuroprotective effects in vivo through CREB-binding protein-dependent mechanisms but does not improve survival in an amyotrophic lateral sclerosis mouse model. ALS, CREB, HDACi, MN, VPA
18  2006 Motor neuron degeneration in amyotrophic lateral sclerosis mutant superoxide dismutase-1 transgenic mice: mechanisms of mitochondriopathy and cell death. ALS, iNOS, MNs
19  2006 The adult neural stem and progenitor cell niche is altered in amyotrophic lateral sclerosis mouse brain. ALS, BrdU, DG, NPCs, NSCs, OB, RMS, SVZa, Tg, wtSOD1
20  2001 Recruitment of the mitochondrial-dependent apoptotic pathway in amyotrophic lateral sclerosis. ALS